Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1139 Results

Title
Intervention Indication Therapeutic Area Year Actions
Eflornithine with lomustine for treating recurrent anaplastic astrocytoma Eflornithine (CPP-1X; Difluoromethylornithine; DFMO; Vaniqa; eflornithine hydrochloride monohydrate) , lomustine Anaplastic astrocytoma Neurological Cancer 2023 View  |  Download
Eflornithine in combination with Sulindac for Familial Adenomatus Polyposis Eflornithine (CPP-1X; Difluoromethylornithine; DFMO; Vaniqa; eflornithine hydrochloride monohydrate) , Sulindac Familial adenomatous polyposis (FAP) Gastroenterology , Genetic Disorders 2018 View  |  Download
Eflornithine for treating neuroblastoma Eflornithine (CPP-1X; Difluoromethylornithine; DFMO; Vaniqa; eflornithine hydrochloride monohydrate) Dermatology , Neuroblastoma Bone and Cartilage Cancer 2021 View  |  Download
Efgartigimod PH20 SC for treating chronic inflammatory demyelinating polyradiculoneuropathy Efgartigimod PH20 SC Chronic inflammatory demyelinating polyradiculoneuropathy Neurology 2023 View  |  Download
Efgartigimod PH20 SC for adults with primary immune thrombocytopenia Efgartigimod PH20 SC Immune thrombocytopenia (ITP) Haematology , Immunology 2023 View  |  Download
Efgartigimod alfa for treating pemphigus vulgaris or pemphigus foliaceus Efgartigimod alfa (ARGX-113) Pemphigus foliaceus , Pemphigus vulgaris Dermatology , Immunology 2023 View  |  Download
Efgartigimod alfa for treating generalised myasthenia gravis Efgartigimod alfa (ARGX-113) Myasthenia gravis (MG) Musculoskeletal System 2021 View  |  Download
Efgartigimod alfa (subcutaneous injection) for treating generalised myasthenia gravis Efgartigimod alfa (ARGX-113) Myasthenia gravis (MG) Musculoskeletal System 2023 View  |  Download
Efanesoctocog alfa for treating and preventing bleeding in people with haemophilia A who have been previously treated Efanesoctocog alfa Haemophilia A Haematology 2022 View  |  Download
Edasalonexent for Duchene muscular dystrophy Edasalonexent (CAT-1004) Duchenne muscular dystrophy (DMD) Genetic Disorders , Musculoskeletal System 2020 View  |  Download
1 2 78 79 80 81 82 113 114
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications